Mylan on March 22 announced a recall of about 81,000 EpiPens distributed in Australia, New Zealand, Europe and Japan after two separate reports of the device failing to work properly during an emergency.
The recall now includes 13 lots of EpiPens distributed by Mylan between December 2015 and July 2016 to the U.S., along with additional markets in Asia, Europe and North and South America, according to the report.
The EpiPens may contain a defective part that prevents them from properly deploying, according to a Food and Drug Administration release.
More articles on supply chain:
Setting lower list prices — a first for pharma?
Swiss hospitals to transport lab samples via drone
4 latest FDA approvals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
